Literature DB >> 15685401

Time to remission and relapse after the first hospital admission in severe bipolar disorder.

Evelyn J Bromet1, Stephen J Finch, Gabrielle A Carlson, Laura Fochtmann, Ramin Mojtabai, Thomas J Craig, Sun Kang, Qing Ye.   

Abstract

BACKGROUND: Few studies of the time to remission and first relapse in severe bipolar disorder have been based on epidemiologically defined samples or have examined patient characteristics and time-varying indicators of medication use simultaneously. Using a cohort from the Suffolk County Mental Health Project, we describe these temporal patterns and their relationships with childhood, illness, and treatment characteristics.
METHOD: A multi-facility cohort of 123 first-admission inpatients with DSM-IV bipolar disorder with psychotic features was followed for 4 years. Dates of the first complete remission (lasting at least 2 months), subsequent relapses, and use of antimanic (AM),antipsychotic (AP), and antidepressant (AD) medications were recorded. Childhood and illness characteristics were ascertained at baseline using standard instruments.
RESULTS: By the 4-year point, 83.7% had achieved a full remission, with 42.3% remitting within 3 months, 63.4% within 6 months, and 74.8% within 1 year. Overall, younger age of onset, history of childhood psychopathology, and higher Brief Psychiatric Rating Scale (BPRS) anxiety/depression scores were significantly associated with longer time to remission. Discontinuing AM, AP and AD (compared to never using) and taking AP and AD (compared to never using) were significantly associated with remission in the multivariate analysis. Of the 103 participants with complete remission, 61.2% suffered a relapse; 24.3 % relapsed within 6 months of remission, and 35.9% within a year. Overall, 32.5% of the 123 participants had a single episode followed by full remission. Childhood internalizing-type problems, higher BPRS anxiety/depression and Hamilton depression scores, and an admission episode not involving mania, but not patterns of medication use, were associated with shorter time to relapse.
CONCLUSION: By 4-year follow-up, the majority of severely ill bipolar patients had remitted from their initial episode, but more than half subsequently relapsed. Illness characteristics, especially depressive symptoms, and medication treatment were associated with the early course, although medication use after remission was not associated with relapse.

Entities:  

Mesh:

Year:  2005        PMID: 15685401     DOI: 10.1007/s00127-005-0864-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  27 in total

1.  Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.

Authors:  J E Schwartz; S Fennig; M Tanenberg-Karant; G Carlson; T Craig; N Galambos; J Lavelle; E J Bromet
Journal:  Arch Gen Psychiatry       Date:  2000-06

2.  Is impaired outcome following a first manic episode due to mood-incongruent psychosis?

Authors:  S M Strakowski; J R Williams; K W Sax; D E Fleck; M P DelBello; M L Bourne
Journal:  J Affect Disord       Date:  2000-12       Impact factor: 4.839

3.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

4.  Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder.

Authors:  Gabrielle A Carlson; Evelyn J Bromet; Corine Driessens; Ramin Mojtabai; Joseph E Schwartz
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

5.  Changes in insurance coverage and extent of care during the two years after first hospitalization for a psychotic disorder.

Authors:  J Rabinowitz; E J Bromet; J Lavelle; K J Hornak; B Rosen
Journal:  Psychiatr Serv       Date:  2001-01       Impact factor: 3.084

6.  Use of antipsychotic drugs and lithium in mania.

Authors:  J Cookson
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

7.  Recurrence in affective disorder. I. Case register study.

Authors:  L V Kessing; P K Andersen; P B Mortensen; T G Bolwig
Journal:  Br J Psychiatry       Date:  1998-01       Impact factor: 9.319

8.  The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Authors:  Mauricio Tohen; Carlos A Zarate; John Hennen; Hari-Mandir Kaur Khalsa; Stephen M Strakowski; Priscilla Gebre-Medhin; Paola Salvatore; Ross J Baldessarini
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder.

Authors:  S Fennig; E J Bromet; M T Karant; R Ram; L Jandorf
Journal:  J Affect Disord       Date:  1996-02-12       Impact factor: 4.839

10.  Relapse and impairment in bipolar disorder.

Authors:  M J Gitlin; J Swendsen; T L Heller; C Hammen
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

View more
  11 in total

1.  Childhood factors associated with increased risk for mood episode recurrences in bipolar disorder-A systematic review.

Authors:  Xavier Estrada-Prat; Anna R Van Meter; Ester Camprodon-Rosanas; Santiago Batlle-Vila; Benjamin I Goldstein; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-05-15       Impact factor: 6.744

2.  Childhood-onset bipolar disorder: Evidence for increased familial loading of psychiatric illness.

Authors:  Richard Rende; Boris Birmaher; David Axelson; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Martin Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-02       Impact factor: 8.829

3.  Early determinants of four-year clinical outcomes in bipolar disorder with psychosis.

Authors:  Gabrielle A Carlson; Roman Kotov; Su-Wei Chang; Camilo Ruggero; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

4.  Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

Authors:  Kaan Kora; Mete Saylan; Cengiz Akkaya; Nesrin Karamustafalioglu; Nesrin Tomruk; Aziz Yasan; Timucin Oral
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study.

Authors:  Ramin Mojtabai; Laura Fochtmann; Su-Wei Chang; Roman Kotov; Thomas J Craig; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2009-06-08       Impact factor: 9.306

6.  Predictors of 30-day rehospitalization in a sample of hospitalized patients with Bipolar I disorder.

Authors:  Melanie L Bozzay; Brandon A Gaudiano; Sarah Arias; Gary Epstein-Lubow; Ivan W Miller; Lauren M Weinstock
Journal:  Psychiatry Res       Date:  2019-09-07       Impact factor: 3.222

7.  The influence of life events on first and recurrent admissions in bipolar disorder.

Authors:  Sanne M Kemner; Neeltje Em van Haren; Florian Bootsman; Marinus Jc Eijkemans; Ronald Vonk; Astrid C van der Schot; Willem A Nolen; Manon Hj Hillegers
Journal:  Int J Bipolar Disord       Date:  2015-02-25

8.  Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand.

Authors:  Thawatchai Leelahanaj; Ronnachai Kongsakon; Somrak Choovanichvong; Sookjaroen Tangwongchai; Suchat Paholpak; Thoranin Kongsuk; Manit Srisurapanont
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-22       Impact factor: 2.570

9.  Modeling association between times to recurrence of the different polarities in bipolar disorder among service seekers in urban Nigeria: a survival analysis approach.

Authors:  Adeniyi Francis Fagbamigbe; Victor Adesola Makanjuola
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-21       Impact factor: 2.570

10.  Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors.

Authors:  In Hee Shim; Young Sup Woo; Hee-Ryung Wang; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.